The Government Accountability Office has found that the Department of Health and Human Services cannot demonstrate how far the National Alzheimer's Project is progressing toward its goals, because it has not set near-term goals with performance measures, quantitative targets and time frames beneath the long-term ones. The report, GAO-26-108498, was published and publicly released on 29 June 2026. It is a question-and-answer review for Congress, based on HHS documentation, National Plan updates from 2012 through 2025, and interviews with officials at the Assistant Secretary for Planning and Evaluation, which leads the project, the National Institutes of Health and the Administration for Community Living. GAO made four recommendations: that HHS give the project's Advisory Council information on the implementation status of individual council recommendations; that it set near-term goals under each long-term goal; that it collect and use performance information for assessment and decision-making; and that it communicate progress to stakeholders in a clear, digestible format. HHS neither agreed nor disagreed, and provided technical comments.
For families, the gap sits directly under the goals that concern them. The National Plan's long-term goals include expanding supports for people with Alzheimer's disease and related dementias and their families, and enhancing care quality and efficiency. GAO reports that HHS stopped including an appendix carrying targets and time frames for some activities from the 2020 National Plan onward, with officials describing the task as onerous and citing a perceived lack of interest in the updates. GAO reviewed the most recent version of that appendix and found it generally did not identify near-term goals with performance measures, quantitative targets and time frames. The 2025 update, released in April 2026 and significantly shorter than its predecessor, did not include them either.
The audit also covers the Advisory Council on Alzheimer's Research, Care, and Services, created by the 2011 act to recommend changes to federal efforts. GAO counted 285 council recommendations made between 2012 and 2024, of which 110 sought to directly increase federal spending; those were most often about ensuring that people living with dementia and their caregivers had access to supports and services, and about federal research capacity. HHS provides periodic updates on recent federal actions informed by some of the recommendations, GAO found, but not the implementation status of individual ones, which the office said would help the council identify remaining gaps.
GAO did not report the project as a failure. It credits the National Alzheimer's Project with expanded support for people with dementia and their caregivers through the Medicare GUIDE Model pilot, which covers comprehensive services including respite, and notes that more than 100 drugs were in clinical trials as of June 2025. The office also says HHS has a timely opening to act, given the project's reauthorization through 2035, the swearing in of new Advisory Council members at the February 2026 meeting, and HHS's stated intention to evaluate and possibly change how the National Plan updates are produced.